Patents Assigned to DEVELOPMENT FOUNDATION
-
Publication number: 20090037507Abstract: A method for multidimensional scaling (MDS) of a data set comprising a plurality of data elements is provided, wherein each data element is identified by its coordinates, the method comprising the steps of: (i) applying an iterative optimization technique, such as SMACOF, a predetermined amount of times on a coordinates vector, said coordinates vector representing the coordinates of a plurality of said data elements, and obtaining a modified coordinates vector; (ii) applying a vector extrapolation technique, such as Minimal Polynomial Extrapolation (MPE) or reduced Rank Extrapolation (RRE) on said modified coordinates vector obtaining a further modified coordinates vector; and (iii) repeating steps (i) and (ii) until one or more predefined conditions are met.Type: ApplicationFiled: June 10, 2008Publication date: February 5, 2009Applicant: Technion Research and Development Foundation Ltd.Inventors: Guy Rosman, Alexander Bronstein, Michael Bronstein, Ron Kimmel
-
Patent number: 7482017Abstract: The present invention concerns isolated attenuated flaviviruses , such as West Nile viruses, having modifications that provide phenotypic varation, particularly in comparison to a more virulent reference strains. The invention encompasses the isolated viruses and immunogenic compositions thereof, in addition to methods to produce and utilize same.Type: GrantFiled: September 9, 2005Date of Patent: January 27, 2009Assignee: Research Development FoundationInventors: Alan D. T. Barrett, Robert B. Tesh, C. Todd Davis, David W. C. Beasley
-
Publication number: 20090019081Abstract: A method for integrating digital maps, each containing a plurality of geographical objects. A three-step integration process is presented. First, geographical objects are retrieved from maps on the Web. Secondly, pairs of objects that represent the same real-world entity, in different maps, are discovered and the information about them is combined. Finally, selected objects are presented to the user. The proposed process is efficient, accurate (i.e., the discovery of corresponding objects has high recall and precision) and it can be applied to any pair of digital maps, without requiring the existence of specific attributes.Type: ApplicationFiled: July 9, 2008Publication date: January 15, 2009Applicants: Technion Research and Development Foundation Ltd., University of Toronto, Yissum Technology Transfer Company of the Hebrew University of JerusalemInventors: Eliyahu Safra, Yaron Kanza, Yehoshua Sagiv, Yerach Doytsher
-
Publication number: 20090008634Abstract: An electronic device is presented, such as a thin film transistor. The device comprises a patterned electrically-conductive layer associated with an active element of the electronic device. The electrically-conductive layer has a pattern defining an array of spaced-apart electrically conductive regions. This technique allows for increasing an electric current through the device.Type: ApplicationFiled: January 9, 2007Publication date: January 8, 2009Applicant: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.Inventors: Nir Tessler, Moti Margalit
-
Patent number: 7466727Abstract: A passive Q-switch for a laser system, and a method for its production. The laser is operative at near infrared wavelength region, including the eye-safe region. The Q-switch includes a saturable absorber based on IV-VI semiconductor nanocrystals (NCs), embedded in a polymer matrix. The NCs preferably include lead selenide, lead sulfide, or lead selenide sulfide. The NCs may be surface passivated, and may feature a PbSe/PbS core-shell configuration.Type: GrantFiled: October 16, 2006Date of Patent: December 16, 2008Assignees: ELOP Electro-Optics Industries Ltd., Technion Research and Development Foundation Ltd.Inventors: Ehud Galun, Efrat Lifshitz, Marina Sirota, Vladimir Krupkin, Aldona Sashchiuk
-
Patent number: 7462646Abstract: The present invention provides a method of reducing or inhibiting osteoclast development induced by the receptor for activation of nuclear factor kappa B ligand (RANKL), comprising the step of contacting said osteoclast, or a precursor of the osteoclast, with a pharmacologically effective dose of compounds such as diferuloylmethane, guggulsterone, 1?-Acetoxychavicol or analogues thereof.Type: GrantFiled: August 25, 2004Date of Patent: December 9, 2008Assignee: Research Development FoundationInventor: Bharat B. Aggarwal
-
Publication number: 20080296534Abstract: The invention relates to a core-alloyed shell semiconductor nanocrystal comprising: (i) a core of a semiconductor material having a selected band gap energy; (ii) a core-overcoating shell consisting of one or more layers comprised of an alloy of the said semiconductor of (i) and a second semiconductor; (iii) and an outer organic ligand layer, provided that the core semiconductor material is not HgTe. Preferably, the core semiconductor material is PbSe and the alloy shell semiconductor material has the PbSexS1-x structure.Type: ApplicationFiled: September 8, 2005Publication date: December 4, 2008Applicant: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.Inventors: Efrat Lifshitz, Ariel Kigel, Maye Brumer-Gilary, Aldona Sashchiuk, Lilac Amirav
-
Patent number: 7459427Abstract: A search of the public human genome database identified a human EST, GenBank accession number AW293249, which has high homology to known pufferfish urocortin sequences. The full length sequence was amplified from human genomic DNA and sequenced. Sequence homology comparisons of the novel sequence with human urocortin I and urocortin II revealed that the sequence encoded a novel human urocortin, which was designated urocortin III (UcnIII). While urocortin III does not have high affinity for either CRF-R1 or CRF-R2, the affinity for CRF-R2 is greater than the affinity for CRF-R1. Urocortin III is capable stimulating cyclic AMP production in cells expressing CRF-R2? or ?. Thus, the affinity is high enough that urocortin III could act as a native agonist of CRF-R2. However, it is also likely that urocortin III is a stronger agonist of a yet to be identified receptor.Type: GrantFiled: August 29, 2005Date of Patent: December 2, 2008Assignee: Research Development FoundationInventors: Wylie W. Vale, Jr., Kathy A. Lewis, Marilyn H. Perrin, Koichi S. Kunitake, Jean E. Rivier, Jozsef Gulyas
-
Publication number: 20080292147Abstract: A method of cropping a representation of a face for electronic processing, said method comprising: selecting a first geodesic contour about an invariant reference point on said face, setting a region within said first geodesic contour as a first mask, selecting a second geodesic contour about a boundary of said identified first region, setting a region within said second geodesic contour as a second mask, and forming a final mask from a union of said first mask and said second mask.Type: ApplicationFiled: March 24, 2008Publication date: November 27, 2008Applicant: Technion Research & Development Foundation Ltd.Inventors: Michael Bronstein, Alexander Bronstein, Ron Kimmel
-
Patent number: 7455839Abstract: Inhibins and activins are protein hormones that reciprocally modulate a diversity of regulatory pathways. Competitive binding experiments revealed that betaglycan, the type III TGF-? receptor, also functions as an inhibin receptor. Betaglycan augments the binding of inhibin to the ActRII activin receptor. By augmenting inhibin binding to ActRII, betaglycan effectively sequesters ActRII away from activin and thereby reduces activin signaling. In addition, the ActRII-betaglycan complex may generate novel signals distinct from those initiated by activin signaling via ActRII and ALK4. Betaglycan is produced in discrete nuclei of the rat brain and by specific cell types within the adult rat pituitary, testis, and ovary. The presence of betaglycan within inhibin-responsive tissues and cell types, together with the ability of this protoglycan to bind inhibin and to confer inhibin sensitivity, is consistent with a role of betaglycan as an inhibin-specific receptor mediating inhibin responses within various tissues.Type: GrantFiled: October 29, 2003Date of Patent: November 25, 2008Assignee: Research Development FoundationInventors: Wylie Vale, Kathy A. Lewis, Peter C. Gray, Louise M. Bilezikjian, Amy L. Blount
-
Publication number: 20080270947Abstract: A method for restricting the number of consequential interactions to further virtual objects having a relationship with a first virtual object, resulting from an interaction with said first virtual object. The method comprises: defining a maximum number of consequential interactions, counting consequential interactions, and stopping further interaction when the maximum number of consequential interactions is reached.Type: ApplicationFiled: July 8, 2008Publication date: October 30, 2008Applicant: Technion Research & Development Foundation Ltd.Inventors: Gershon Elber, Orit Shaked, Oded Shmueli
-
Publication number: 20080253688Abstract: Systems and methods for integrating maps in which roads are represented as polylines. The main novelty of the invention is in using only the locations of the endpoints of the polylines rather than trying to match whole lines. Experiments on real-world data are given, showing that this approach of integration based on matching merely endpoints is efficient and accurate (that is, it provides high recall and precision).Type: ApplicationFiled: April 9, 2008Publication date: October 16, 2008Applicants: Technion Research and Development Foundation Ltd., Yissum Research and Development Company of The Hebrew University of Jerusalem, The University of TorontoInventors: Eliyahu SAFRA, Yaron Kanza, Yehoshua Sagiv, Yerach Doytsher
-
Publication number: 20080248995Abstract: A method for detecting a modulator of transcription of a human PPAR gene promoter is provided, comprising contacting a candidate compound with a cell transfected with an expression vector containing a heterologous gene operably linked to a PPAR promoter and an additional expression vector containing the FOXO1 gene, and comparing the level of expression of said heterologous gene in the presence of the compound and in the absence thereof, whereby a modulator of transcription of the human PPAR gene promoter is identified. The PPAR gene promoter is preferably the PPAR?2 promoter, and the DNA-binding domain of the FOXO1 protein binds to a sequence encompassing the 63 to 323 bp region of the human PPAR?2 promoter, preferably the 270 to 310 bp region.Type: ApplicationFiled: May 31, 2007Publication date: October 9, 2008Applicant: Technion Research and Development Foundation Ltd.Inventors: Eddy Karnieli, Michal Armoni
-
Publication number: 20080246398Abstract: A mirror magnetic field forming device is disposed in each discharge unit space (or discharge cell) of a plasma display panel. The mirror magnetic field forming device is formed by providing magnetic members for respective two bulkheads facing each other through the discharge unit space. The two magnetic members form a mirror magnetic field in the discharge unit space. The mirror magnetic field prevents electrons from colliding with the bulkheads and disappearing.Type: ApplicationFiled: January 17, 2006Publication date: October 9, 2008Applicant: Technion Research & Development Foundation Ltd.Inventor: Noriyoshi Shida
-
Patent number: 7432081Abstract: Novel genes encoding homologous immunoreactive thio-disulfide oxidoreductases, or disulfide bond formation (Dsb) proteins from Ehrlichia chaffeensis and Ehrlichia canis are disclosed. While the E. chaffeensis and E. canis Dsb proteins are at most only 31% or less homologous to other known Dsb proteins, the Ehrlichia Dsbs contain a cysteine active site, Cys-Gly-Tyr-Cys, similar to those in known Dsb proteins. As predicted by 15-amino acid identical N-terminal signal peptides, the proteins are primarily localized in the periplasm of E. chaffeensis and E. canis, possibly playing a role in antigenicity and pathogenesis. The present invention provides the nucleotide and amino acid sequences and expression vectors for the E. chaffeensis and E. canis dsb genes, antisera directed against the proteins, and kits to determine whether an individual or animal is infected with a given species of Ehrlichia.Type: GrantFiled: November 1, 2002Date of Patent: October 7, 2008Assignee: Research Development FoundationInventors: David H. Walker, Jere W. McBride
-
Publication number: 20080235251Abstract: The present invention relates to a method, and system for implementing the method, for performing incremental validation of an XML document with respect to XML Schema key and keyref constraints, and handling the semantics dictated by the XML Schema specification. Several operations are defined that change the content of a document, i.e., add or remove nodes, or change the value of existing nodes. The present invention verifies whether performing such an operation would violate key or keyref constraints, and allows changing the document only if the operation maintains the validity of the document with respect to the constraints. The verification traverses only the parts of the document that may be affected by the change operation, and not the whole document. The invention maintains, in an efficient manner, data structures that hold information relevant to the validation of key and keyref constraints.Type: ApplicationFiled: July 27, 2006Publication date: September 25, 2008Applicant: Technion Research and Development Foundation Ltd.Inventors: Oded Shmueli, Sharon Krisher
-
Publication number: 20080232643Abstract: System and method for visually tracking a target object silhouette in a plurality of video frames under very general conditions. The tracker does not make any assumption about the object or the scene. The tracker works by approximating, in each frame, a PDF (probability distribution function) of the target's bitmap and then estimating the maximum a posteriori bitmap. The PDF is marginalized over all possible motions per pixel, thus avoiding the stage in which optical flow is determined. This is an advantage over other general-context trackers that do not use the motion cue at all or rely on the error-prone calculation of optical flow. Using a Gibbs distribution with a first order neighborhood system yields a bitmap PDF whose maximization may be transformed into that of a quadratic pseudo-Boolean function, the maximum of which is approximated via a reduction to a maximum-flow problem.Type: ApplicationFiled: March 23, 2007Publication date: September 25, 2008Applicant: Technion Research & Development Foundation Ltd.Inventors: Ido Leichter, Michael Lindenbaum, Ehud Rivlin
-
Publication number: 20080224703Abstract: A device for NMR spectroscopy is disclosed. The device comprises a sealed capillary having therein a lock material.Type: ApplicationFiled: March 12, 2008Publication date: September 18, 2008Applicant: Technion Research & Development Foundation Ltd.Inventors: Gregory Molev, Dmitry Bravo-Zhivotovskii
-
Publication number: 20080220036Abstract: An antimicrobial packaging material for food stuffs containing from 0.05% to 1.5% by weight of a natural essential oil. The oil can be selected from primarily linalool and/or methylchavicol, but also from one or more of citral, geraniol, methyl cinnamate, methyl eugenol, 1,8-cineole, trans-a-bergamotene, carvacrol and thymol blended with one or more polymers selected from ethylene vinyl alcohol copolymer, polyacrylates, including ethyl acrylate methyl methacrylate copolymers, lonomers, nylons and other hydrophilic polymers or polymers possessing functional groups capable of partially anchoring the additives and the blender mix is coated onto the food contact face of a food grade packaging film or incorporated into a food grade packaging film. A binding agent such as polyethylene glycol is added to the blend to improve the retention of the volatile oil in the polymer during processing. This material has no regulatory limitations and, at the referred concentrations, does not form detectable off-flavours.Type: ApplicationFiled: June 27, 2005Publication date: September 11, 2008Applicants: VICTORIA UNIVERSITY, TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.Inventors: Joseph Miltz, Stephen William Bigger, Cornelis Sonneveld, Pannuwat Suppakul
-
Patent number: 7423794Abstract: A multi-level decoupled micro-actuator device comprising a first level substrate (410), a second level frame (420) stacked on said first level substrate (410), a third level frame (430) stacked on said second level frame (420).Type: GrantFiled: February 15, 2004Date of Patent: September 9, 2008Assignee: Technion Research & Development Foundation Ltd.Inventors: David Elata, Ofir Bochobza-Degani, Yael Nemirovsky